CD274 and neoplasm: We had demonstrated the potential of macrophage abundance and 3-gene signature to predict the immunotherapy efficacy from multiple perspectives, such as Tumor Mutational Burden (TMB), PD-L1, immune-related liquid molecules, immune checkpoints, STAD molecular subtype analysis and gene mutation.